CH5015765 is an orally available Hsp90 inhibitor bound to the N-terminal ATP binding site, with a dissociation constant of 3.4 nM, CH5015765 exerts antiproliferative activity against human cancer cell lines, with IC50 values of 0.46 µM for HCT116 colorectal cancer cells and 0.57 µM for NCI-N87 gastric cancer cells. CH5015765 can be used for the study of cancer[1][2].
Molecular Weight:
344.82
Purity:
98.01
CAS Number:
[959766-47-3]
Formula:
C16H13ClN4OS
Target:
HSP
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
